Is Four More Months of Life Worth $93,000?

Medicare officials recently announced  that the Medicare program will pay the $93,000 cost of prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.

Comments are closed.